Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 35

Sort by

Sort Order Select

Journal Articles

Outcome of Transformed Fanconi Anaemia Patients after Hematopoietic Stem Cell Transplantation: Analysis on Behalf of European Group for Blood and Marrow Transplantation

Blood (2018) 132 (Supplement 1): 646.

https://doi.org/10.1182/blood-2018-99-115399

Published: 2018

Journal Articles

Adhering to Recommended Lifestyle Changes and Medications 9 Months to 3 Years after Hematopoietic Stem Cell Transplant: Self-Reported Adherence and the Practical, Psychological, and Social Correlates of Adherence

Christine Rini, PhD, Jane Austin, PhD, Lisa Wu, PhD, Heiddis Valdimarsdottir, PhD, Pashna N. Munshi, MD, Andre Goy, MD, Scott D. Rowley, MD

Blood (2018) 132 (Supplement 1): 4799.

https://doi.org/10.1182/blood-2018-99-119467

Published: 2018

Journal Articles

Myeloablative Conditioning with Alemtuzumab in Matched Related Donor Hematopoietic Cell Transplant for Sickle Cell Disease Prevents Graft-Versus-Host Disease without Compromising Engraftment

Tami D John, MD, Khaled Yassine, MD, Swati Naik, MBBS, Ghadir Sasa, MD, Bilal Omer, MD, Caridad A. Martinez, MD, Priti Tewari, MD, Robert A. Krance, MD, Kathryn S Leung, MD

Blood (2018) 132 (Supplement 1): 2086.

https://doi.org/10.1182/blood-2018-99-113856

Published: 2018

Journal Articles

Effective Treatment of Thrombotic Microangiopathy Associated with Lupus Nephritis with Eculizumab: a Series of 8 Cases

Mihee Park, MD BS, Ilene Ceil Weitz, MD

Blood (2017) 130 (Supplement 1): 1043.

https://doi.org/10.1182/blood.V130.Suppl_1.1043.1043

Published: 2017

Journal Articles

Genomic and Biochemical Proteasomal Adaptations in Carfilzomib-Resistant Plasma Cells That Limit HLA-Desensitization in Transplantation Candidates

James Driscoll, MD PhD, Simon Tremblay, PharmD, Nupur Dasgupta, PhD, Bruce Aronow, PhD, Harinder Singh, PhD, E. Steve Woodle, MD

Blood (2017) 130 (Supplement 1): 5448.

https://doi.org/10.1182/blood.V130.Suppl_1.5448.5448

Published: 2017

Journal Articles

Allogeneic Stem Cell Transplantation for the Treatment of Lymphoproliferative Disorders in Patients Affected By Primary Immunodeficiencies: The UK Experience

Giulia Prunotto, Giovanna Lucchini, MD, Sujith Samarasinghe, Robert Wynn, MD, Ajay Vora, MD, Ben Carpenter, Claire Gowdy, Kieran Mchugh, Andrew Gennery, MD, Paul Veys, MD PhD, Christopher Bacon, Simon Bomken

Blood (2017) 130 (Supplement 1): 4573.

https://doi.org/10.1182/blood.V130.Suppl_1.4573.4573

Published: 2017

Journal Articles

Evolution of Monoclonal Gammopathy of Undetermined Significance in Kidney Transplant Recipients at the CHUM (Centre Hospitalier de l'Université de Montréal) — a Single-Institution Retrospective Study

Marie-France Gagnon, MD, Héloïse Cardinal, MDPhD, Jean-Pierre Emond, PhD, Bernard Lemieux, MD

Blood (2017) 130 (Supplement 1): 4366.

https://doi.org/10.1182/blood.V130.Suppl_1.4366.4366

Published: 2017

Journal Articles

Hemophilia Liver Transplant Observational Study (HOTS)

Margaret V. Ragni, MD, Abhinav Humar, MD, Peter G. Stock, MD PhD, Emily A. Blumberg, MD, Bijan Eghtesad, MD, John Fung, MD PhD, Valentina Stosor, MD, Nicholas NIssen, MD, Michael T. Wong, MD, Kenneth E. Sherman, Donald Stablein, PhD, Burc Barin, MS

Blood (2016) 128 (22): 3782.

https://doi.org/10.1182/blood.V128.22.3782.3782

Published: 2016

Journal Articles

Can Memory T Cell Monitoring Using Flow Cytometry Predict Survival in Haploidentical Hematopoietic Stem Cell Transplantation?

Bohyun Kim, MD PhD, Seongsoo Jang, MD PhD, Yu-Jin Lee, Young-Uk Cho, MD PhD, Chan-Jeoung Park, MD PhD, Eun-Seok Choi, Kyung-Nam Koh, MD PhD, Ho Joon Im, MD PhD, Jong Jin Seo, MD PhD

Blood (2016) 128 (22): 4591.

https://doi.org/10.1182/blood.V128.22.4591.4591

Published: 2016

Journal Articles

Use of hematopoietic cell transplants to achieve tolerance in patients with solid organ transplants

Samuel Strober

Blood (2016) 127 (12): 1539–1543.

https://doi.org/10.1182/blood-2015-12-685107

Published: 2016

Journal Articles

Favorable Results of Allo-HSCT from MRD in Patients with Myelofibrosis

Miroslaw Markiewicz, MD PhD, Monika Dzierzak-Mietla, MD PhD, Patrycja Zielinska, MD PhD, Agata Wieczorkiewicz-Kabut, MD PhD, Sylwia Mizia, MSci, Mariusz Matyja, MD, Krzysztof Bialas, MD, Grzegorz Helbig, MD PhD Prof., Anna Koclega, MD PhD, Malwina Rybicka, MD, Lech Sedlak, Tomasz Oleksy, Slawomira Kyrcz-Krzemien, MD PhD Prof.

Blood (2014) 124 (21): 5934.

https://doi.org/10.1182/blood.V124.21.5934.5934

Published: 2014

Journal Articles

Non-Myeloablative Conditioning Targeting Host Immunosuppression Is Successful in Matched Sibling Donor Stem Cell Transplantation for Hemoglobinopathies in Children

Blood (2014) 124 (21): 3873.

https://doi.org/10.1182/blood.V124.21.3873.3873

Published: 2014

Journal Articles

Lineage-Specific Chimerism Monitoring Using Flow Cytometry with Anti HLA-Antibodies in Haploidentical Hematopoietic Stem Cell Transplantation

Bo Hyun Kim, MD, Seongsoo Jang, MD PhD, Yu-jin Lee, Nuree Park, Young-Uk Cho, MD PhD, Chan-Jeoung Park, MD PhD, Eun-Seok Choi, Jin-Kyung Seo, Seong-Uk Lee, Kyung-Nam Koh, MD PhD, Ho Joon Im, MDPhD, Jong Jin Seo, MD

Blood (2014) 124 (21): 3921.

https://doi.org/10.1182/blood.V124.21.3921.3921

Published: 2014

Journal Articles

Favorable T Cell Reconstitution In Reduced Intensity Conditioned Allogeneic Stem Cell Transplantation with Low-Dose Rabbit Anti-Thymocyte Globulin and Total Body Irradiation

Radhika Thorn, MD, Jeremy Meier, BS, Elaine Wang, MD, Roy T Sabo, PhD, Allison F Scalora, MS, Catherine H Roberts, PhD, Shiyu Song, MD, PhD, Masoud H Manjili, DVM, PhD, William B Clark, MD, John M McCarty, MD, Harold M Chung, MD, Amir A Toor, MD

Blood (2013) 122 (21): 4577.

https://doi.org/10.1182/blood.V122.21.4577.4577

Published: 2013

Journal Articles

Adverse Cytogenetic Abnormalities At Diagnosis Are The Most Important Predictor Of Relapse Post T Cell Depleted (TCD) Allogeneic Hematopoietic Stem Cell Transplantation In Patients With Advanced Myelodysplastic Syndrome (MDS)

Roni Tamari, MD, Ann A. Jakubowski, MD, PhD, Esperanza B. Papadopoulos, MD, Sergio A Giralt, MD, Jenna D Goldberg, MD, Doris M Ponce, MD, Craig S. Sauter, MD, Patrick Hilden, MS, Sean Devlin, PhD, James W. Young, MD, Hugo Castro-Malaspina, MD

Blood (2013) 122 (21): 3379.

https://doi.org/10.1182/blood.V122.21.3379.3379

Published: 2013

Journal Articles

Allogeneic Hematopoietic Stem Cell Transplantation Is Feasible After Solid Organ Transplantation: A Retrospective Analysis By The Early Complications Subcommittee Of The Complications and Quality Of Life Working Party, EBMT

Grzegorz W. Basak, MD, PhD, Wieslaw W. Jedrzejczak, MD, PhD, Helene Schoemans, MD, Per T. Ljungman, MD, PhD, Guido Kobbe, MD, Yves Beguin, MD, PhD, Peter Lang, MD, Karl-Walter Sykora, MD, Liane CJ te Boome, MD, Anja van Biezen, Steffie van der Werf, Mohamad Mohty, MD, PhD, Theo de Witte, MD, Judith Marsh, Peter Dreger, MD, Nicolaus Kroeger, MD, Rafael F. Duarte, MD, PhD, Tapani Ruutu, MD PhD

Blood (2013) 122 (21): 2110.

https://doi.org/10.1182/blood.V122.21.2110.2110

Published: 2013

Journal Articles

Update On Phase 2 Clinical Trial To Induce Tolerance In Mismatched Living Donor Renal Transplant Recipients

Joseph Leventhal, MD, PhD, Michael Abecassis, MD, Joshua Miller, MD, Lorenzo Gallon, MD, David J Tollerud, MD, MPH, Suzanne T. Ildstad, MD

Blood (2013) 122 (21): 4622.

https://doi.org/10.1182/blood.V122.21.4622.4622

Published: 2013

Journal Articles

Post-Transplantation Lymphoproliferative Disorders (PTLD) Management in Solid Organ Transplantation (SOT) Recipients

Nikolai A. Podoltsev, MD, PhD, Ivan Bustillo, MD, Xiaopan Yao, PhD, Haibei Liu, Dennis L. Cooper, MD

Blood (2011) 118 (21): 4941.

https://doi.org/10.1182/blood.V118.21.4941.4941

Published: 2011

Journal Articles

Long-Term Follow-up of Adults with Severe Sickle Cell Disease After Hematopoietic Stem Cell Transplantation Using Reduced Intensity Conditioning

Melinda A Biernacki, MD, Maureen Okam, MD, Shalini Shenoy, MD, Lakshmanan Krishnamurti, Associate, Professor, Pediatrics, Mitchell E. Horwitz, MD, Donna Neuberg, ScD, Joseph H. Antin, MD, Catherine J Wu, MD

Blood (2010) 116 (21): 261.

https://doi.org/10.1182/blood.V116.21.261.261

Published: 2010

Journal Articles

Post-Transplant Immune Suppressive Therapy Is Not Necessary In Related and Unrelated Reduced Intensity Conditioning Stem Cell Transplantation Using Low Dose Alemtuzumab In Vivo T Cell Depletion Combined with Alemtuzumab-Mediated In Vitro T Cell Depletion of the Graft

P.A. Von Dem Borne, MD, PhD, C.J.M. Halkes, MD, PhD, C.W.J. Starrenburg, W.A.F. Marijt, MD, PhD, J.H.F. Falkenburg, MD, PhD

Blood (2010) 116 (21): 2328.

https://doi.org/10.1182/blood.V116.21.2328.2328

Published: 2010

NARROW

Outcome of Transformed Fanconi Anaemia Patients after Hematopoietic Stem Cell Transplantation: Analysis on Behalf of European Group for Blood and Marrow Transplantation

Adhering to Recommended Lifestyle Changes and Medications 9 Months to 3 Years after Hematopoietic Stem Cell Transplant: Self-Reported Adherence and the Practical, Psychological, and Social Correlates of Adherence

Myeloablative Conditioning with Alemtuzumab in Matched Related Donor Hematopoietic Cell Transplant for Sickle Cell Disease Prevents Graft-Versus-Host Disease without Compromising Engraftment

Effective Treatment of Thrombotic Microangiopathy Associated with Lupus Nephritis with Eculizumab: a Series of 8 Cases

Genomic and Biochemical Proteasomal Adaptations in Carfilzomib-Resistant Plasma Cells That Limit HLA-Desensitization in Transplantation Candidates

Allogeneic Stem Cell Transplantation for the Treatment of Lymphoproliferative Disorders in Patients Affected By Primary Immunodeficiencies: The UK Experience

Evolution of Monoclonal Gammopathy of Undetermined Significance in Kidney Transplant Recipients at the CHUM (Centre Hospitalier de l'Université de Montréal) — a Single-Institution Retrospective Study

Hemophilia Liver Transplant Observational Study (HOTS)

Can Memory T Cell Monitoring Using Flow Cytometry Predict Survival in Haploidentical Hematopoietic Stem Cell Transplantation?

Use of hematopoietic cell transplants to achieve tolerance in patients with solid organ transplants

Favorable Results of Allo-HSCT from MRD in Patients with Myelofibrosis

Non-Myeloablative Conditioning Targeting Host Immunosuppression Is Successful in Matched Sibling Donor Stem Cell Transplantation for Hemoglobinopathies in Children

Lineage-Specific Chimerism Monitoring Using Flow Cytometry with Anti HLA-Antibodies in Haploidentical Hematopoietic Stem Cell Transplantation

Favorable T Cell Reconstitution In Reduced Intensity Conditioned Allogeneic Stem Cell Transplantation with Low-Dose Rabbit Anti-Thymocyte Globulin and Total Body Irradiation

Adverse Cytogenetic Abnormalities At Diagnosis Are The Most Important Predictor Of Relapse Post T Cell Depleted (TCD) Allogeneic Hematopoietic Stem Cell Transplantation In Patients With Advanced Myelodysplastic Syndrome (MDS)

Allogeneic Hematopoietic Stem Cell Transplantation Is Feasible After Solid Organ Transplantation: A Retrospective Analysis By The Early Complications Subcommittee Of The Complications and Quality Of Life Working Party, EBMT

Update On Phase 2 Clinical Trial To Induce Tolerance In Mismatched Living Donor Renal Transplant Recipients

Post-Transplantation Lymphoproliferative Disorders (PTLD) Management in Solid Organ Transplantation (SOT) Recipients

Long-Term Follow-up of Adults with Severe Sickle Cell Disease After Hematopoietic Stem Cell Transplantation Using Reduced Intensity Conditioning

Post-Transplant Immune Suppressive Therapy Is Not Necessary In Related and Unrelated Reduced Intensity Conditioning Stem Cell Transplantation Using Low Dose Alemtuzumab In Vivo T Cell Depletion Combined with Alemtuzumab-Mediated In Vitro T Cell Depletion of the Graft

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only